We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
eWellness Healthcare Corporation (CE) | USOTC:EWLL | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.000001 | 0.000001 | 0.000001 | 0.000001 | 3,455,000 | 00:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
☐ Form 10-K | ☐ Form 20-F | ☐Form 11-K | ☒ Form 10-Q |
☐ Form 10-D | ☐ Form N-SAR | ☐ Form N-CSR |
For Period Ended: June 30, 2022
☐ Transition Report on Form 10-K | ☐ Transition Report on Form 10-Q |
☐ Transition Report on Form 20-F | ☐ Transition Report on Form 11-K |
☐ Transition Report on Form N-SAR |
For the Transition Period Ended: _______________________________________
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.
If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:
PART I
REGISTRANT INFORMATION
Full name of registrant: | eWellness Healthcare Corporation | |
Former name if applicable: | ||
Address of principal executive office: | 1126 S Federal Hwy #464 | |
City, state and zip code | Fort Lauderdale, FL 33316 |
PART II
RULES 12b-25 (b) AND (c)
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
☒ | The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; |
☒ | The subject annual report, semi-annual report, transition report on Forms 10-K, 20-F, 11-K, N-SAR, or N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and an accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |
PART III
NARRATIVE
State below in reasonable detail the reasons why Forms 10-K, 11-K, 20-F, 10-Q, 10-D, N-SAR, N-CSR, or the transition report portion thereof, could not be filed within the prescribed time period.
The Registrant is currently in the process of completing the process of compiling and disseminating the information required to be included in its Quarterly Report on Form 10-Q for the quarter ended June 30, 2022, as well as the required review of the Registrant’s financial information. The Registrant is not able to complete the process without incurring undue hardship and expense. The Registrant will require additional time to complete and file its Form 10-Q for the quarter ended June 30, 2022, and plans to file it by August 19, 2022.
PART IV
OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this notification
Chris Patterson | (860) | 884-5694 | ||
(Name) | (Area Code) | (Telephone Number) |
(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).
☒ Yes ☐ No
(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
☐ Yes ☒ No
If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
eWellness Healthcare Corporation
Name of Registrant as Specified in Charter.
Has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.
eWellness Healthcare Corporation | ||
August 15, 2022 | By: | /s/ Chris Patterson |
Name: | Chris Patterson | |
Title: | Interim Chief Executive Officer |
1 Year eWellness Healthcare (CE) Chart |
1 Month eWellness Healthcare (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions